Payer Dossiers
Country-specific value dossiers, HTA submissions, and payer-facing evidence packages — adapted for local health technology assessment requirements.
What you get
Value dossier
Comprehensive payer submission with clinical, economic, and comparative evidence
HTA response document
Structured answers to HTA body questions and assessment criteria
Payer objection matrix
Anticipated objections with evidence-backed response strategies
Country-specific HTA logic
Every dossier maps local HTA criteria, comparator requirements, and economic evidence thresholds — not generic global arguments.
Payer-facing language
Arguments structured for reimbursement committees and payer advisors — clinical evidence translated into value language.
Cross-market scalability
One core evidence base adapted for multiple country submissions in parallel.
About this service
HTA dossiers built for payer decisions
Reimbursement decisions depend on local evidence requirements. A global value dossier rarely meets the specific criteria of local HTA bodies — different comparators, different endpoints, different economic thresholds.
We build payer dossiers tailored to specific country HTA processes — from NICE and G-BA to local CEE and MENA authorities. Every submission maps clinical evidence to local payer logic with the right comparators, economic framing, and outcome measures.
AI accelerates evidence extraction and cross-referencing — while health economics experts and medical writers build the payer argument.
Deliverables
What you get
Value dossier
Comprehensive payer submission with clinical, economic, and comparative evidence
HTA response document
Structured answers to HTA body questions and assessment criteria
Payer objection matrix
Anticipated objections with evidence-backed response strategies
Budget impact model inputs
Clinical and economic data formatted for pharmacoeconomic modeling
Reimbursement summary
Executive-level overview for internal access strategy teams
Tender support package
Evidence and pricing documentation for hospital or national tenders
How we work
Five phases to HTA-ready submissions
01
Map HTA requirements
Identify local submission criteria, comparators, and economic thresholds.
02
Assemble evidence base
Extract relevant clinical, safety, and economic data from source documents.
03
Build payer argument
Structure evidence into a compelling value narrative for local payers.
04
Draft dossier
Write the full submission document following local HTA format requirements.
05
Review & finalize
Expert review for accuracy, completeness, and submission readiness.
AI-enabled workflow
AI-accelerated data assembly, expert-built arguments
AI extracts and cross-references clinical and economic data. Health economics experts and medical writers build the payer-facing argument.
What AI does
- Clinical data extraction from trial publications and CSRs
- Cross-reference checking between data sources
- Comparator evidence landscape mapping
- Draft table and figure generation
What MAG experts do
- Local HTA requirement interpretation and mapping
- Health economics argumentation and value framing
- Payer objection anticipation and response development
- Final dossier writing and submission formatting
Evidence Scanner™ modules used
PubMed/Web Monitoring
Fact-Checker
Literature Triage
Proof
How this service works in practice
Global value dossier localized for 5 MENA markets: SGLT2 inhibitor in heart failure
Result:Positive reimbursement in 3/5 markets within 12 months
Cardiology
Read case →
Payer objection handling matrix for CDK4/6 inhibitor across CEE markets
Result:Objection-response pairs used in 4 successful submissions
Oncology
Read case →
Biosimilar switching evidence dossier for 6 EU market access submissions
Result:Used in tender submissions across all 6 markets
Immunology
Read case →
Solves these challenges
Related problems
RWE exists but was never turned into a usable HTA dossier
The data has been collected, but no one built the payer-facing argument from it.
See how we solve it →
Global dossier uses wrong comparator for local HTA
The value argument doesn’t hold when the local payer evaluates against a different comparator.
See how we solve it →
HQ materials don’t meet local HTA requirements
Affiliate access teams need country-specific evidence packages, not global slide decks.
See how we solve it →
Frequently asked
Common questions
Which HTA processes do you cover?
We have experience with NICE, G-BA, HAS, AIFA, local CEE HTA bodies, and MENA regulatory frameworks. We adapt to any country-specific submission format.
Can you support multiple markets in parallel?
Yes. We build from a shared evidence core and adapt for each market’s specific HTA requirements, comparators, and economic context.
Do you build pharmacoeconomic models?
We provide clinical and economic data inputs for budget impact and cost-effectiveness models. For full modeling, we work with specialized health economics partners.
How do you handle payer objections?
We build objection matrices based on prior HTA feedback and local payer patterns — with evidence-backed response strategies for each anticipated challenge.
Can you support post-submission defense?
Yes. We prepare response documents for HTA body questions and support the defense process with additional evidence and argumentation.
Need an HTA-ready dossier?
Tell us your market and product. We’ll scope the submission requirements and propose a plan.
Book a scoping call →
Browse all services
Need payer evidence that wins reimbursement?
Tell us your market, comparator, and timeline. We’ll build a dossier that meets local HTA requirements.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Electronic data capture with AI-assisted quality checks
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// HTA dossier evidence assembly
assemble("hta_submission_requirements.json", {
mode: "value_dossier",
markets: 5,
output: "dossier_draft + objection_matrix",
})
Mapping HTA criteria across 5 markets...
Evidence Map
5 market profiles mapped. 3 require different primary comparator. 2 markets need additional RWE data. Objection matrix: 12 anticipated challenges with evidence responses...